Canada implemented its patent term extension program, the Certificate of Supplementary Protection (CSP) framework, on September 21, 2017. The CSP regime is beneficial to qualifying pharmaceutical product developers because it can add up to two additional years of patent protection. Notably, CSP is not as beneficial as other major jurisdictions, which generally allow up to